Comparative study evaluating efficacy of sufentanil versus midazolam in preventing myoclonic movements following etomidate
Background and Aims: Myoclonus is a major side-effect following etomidate injection requiring use of medical intervention. Material and Methods: In this double-blinded clinical trial, 50 consecutive patients, randomly received sufentanil 0.2 μg/kg or midazolam 0.015 mg/kg, 90 s before induction of a...
Saved in:
Main Authors: | Mohammad Alipour (Author), Masoumeh Tabari (Author), Azadeh Mokhtari Azad (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comparison of midazolam and dexmedetomidine for the prevention of myoclonic movements and pain following etomidate injection
by: Sema Aktolga, et al.
Published: (2010) -
Efficacy and Safety of Etomidate in Comparison with Propofol or Midazolam as Sedative for Upper Gastrointestinal Endoscopy
by: Jae Hyun Kim, et al.
Published: (2020) -
Effect of priming in preventing myoclonic movements after intravenous induction with etomidate in adult patients undergoing cardiac surgery: a randomised controlled interventional study
by: Mukesh K Sunda, et al.
Published: (2022) -
Nausea and vomiting after spinal anesthesia with two drugs combinations of bupivacaine- fentanyl and bupivacaine-sufentanil during cesarean section
by: Mohammad Alipour, et al.
Published: (2021) -
Comparison of pretreatment with dexmedetomidine with midazolam for prevention of etomidate-induced myoclonus and attenuation of stress response at intubation: A randomized controlled study
by: Swarnendu Dey, et al.
Published: (2018)